Skip to content
Screener

Tarsus Pharmaceuticals, Inc. TARS Common stock voting rights, number of votes

Common stock voting rights, number of votes at other companies

PCS
PCSCPCSC
10.0%
Remitly Global, Inc. logo
Remitly Global, Inc.RELY
$10.0%
Remitly Global, Inc. logo
Remitly Global, Inc.RELY
10.0%
Hippo Holdings logo
Hippo HoldingsHIPO
10.0%
PBH
Prestige Consumer HealthcarePBH
$10.0%
PBH
Prestige Consumer HealthcarePBH
10.0%

Other financials

Income statement

See full
Revenue$173.9M+69.4%
Gross profit$161.8M+67.8%
Operating income-$19.9M+10.3%
Net income-$18.6M+8.8%
EPS (diluted)-$0.43+10.4%

Balance sheet

See full
Cash & equivalents$206.6M+108%
Total debt$88.8M+22.6%
Total equity$346.7M+4.2%
Total assets$611.1M+23.5%

Cash flow

See full
Operating cash flow$61.2M+308%
CapEx$4.1M+306%
Free cash flow$57.2M+288%

Valuation

See full
Market cap$2.97B+40.7%
Enterprise value$2.86B+36.8%
P/S4.9×-2.2×

Profitability

See full
Gross margin79.8%
Operating margin-8%-3.5pp
Net margin-7.7%-3.3pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-13.7%-4.9pp
Debt / equity0.3×0.0×
Current ratio3.2×-2.1×

Where this comes from

Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept tars:CommonStockNumberOfVotes.

The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:25 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001819790-26-000064

As of June 30, 2026 and December 31, 2025, the Company had 43,271,347 and 42,553,931 shares of common stock issued and outstanding, respectively, which excludes 312,500 of pre-funded warrants that remained exercisable at both period ends and are reserved for future issuance. Common stockholders have one vote for each share of common stock held and are entitled to receive dividends declared by the Company’s Board of Directors when legally available for distribution, then-subject to the dividend rights of the holders of preferred stock.

Item 1. Financial Statements

FAQ

What is Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes?
Tarsus Pharmaceuticals, Inc. (TARS) reported common stock voting rights, number of votes of $1 in Q2 2026.
How has Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes decreased by 0.0% year-over-year, from $1 to $1.
What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes?
Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes has grown at a 0.0% compound annual growth rate (CAGR), from $1 to $1.
What does common stock voting rights, number of votes mean?
Common stock voting rights, number of votes as reported by Tarsus Pharmaceuticals, Inc. Common Stock.

Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock voting rights, number of votes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude